Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of Exxenterol for reducing serum cholesterol
2005-000990-22Phase 2Active
- Sponsor
- Exxentia
- Start
- Sep 2005
- Countries
- 1
01
Overview
Phase 2 trial of Exxenterol in hypercholesterolemia, sponsored by Exxentia. Primary endpoint: Change in total serum cholesterol. Started Sep 2005; status: active.
02
Drugs
Exxenterol
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on 2005-000990-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000990-22.